Questioning the clinical significance of Salacia oblonga.
Clemens
Roger A
RA
Pressman
Peter
P
D001786:Blood Glucose / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000097:blood / Q000453:epidemiology / Q000517:prevention & control; D029753:Celastraceae / Q000737:chemistry*; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D005234:Fatty Liver / Q000517:prevention & control; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D024821:Metabolic Syndrome / Q000188:drug therapy; D010936:Plant Extracts / Q000009:adverse effects / Q000627:therapeutic use
D001786:Blood Glucose; D004791:Enzyme Inhibitors; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D010936:Plant Extracts